Your browser doesn't support javascript.
loading
Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study.
Khorshiddoust, Reza Ramazani; Khorshiddoust, Saleh Ramazani; Hosseinabadi, Tahereh; Mottaghitalab, Faezeh; Mokhtari, Farzad; Azadinia, Fatemeh; Mozdarani, Hossein; Shabani, Mohammad; Emadi-Kouchak, Hamid; Taheri, Bahram; Khani-Juyabad, Fatemeh; Kashani, Mina Amjadi; Sadoughi, Arezoo; Zamanizadeh, Sorour; Maddah, Hadyeh; Aminzadeh, Maedeh; Khanaki, Maryam; Saremi, Sabereh; Rad, Anahita Pashaee; Fatehi, Ali; Rad, Melika Ghaznavi; Haftbaradaran, Masoud; Khosroshahi, Mehran; Sadeghi, Mahtab; Aminnayeri, Majid; Jafari, Sirous; Ghiasvand, Fereshteh; Seifi, Arash; Ghaderkhani, Sara; Manshadi, Seyed Ali Dehghan; Salehi, Mohammadreza; Abbasian, Ladan; Hasannezhad, Malihe; Meidani, Mohsen; Hajiabdolbaghi, Mahboubeh; Ahmadinejad, Zahra; Parash, Masoud; Sedighi, Zahra; Mohammadian, Abdorreza.
Afiliação
  • Khorshiddoust RR; R&D Group, MIM Pharma, Oslo, Norway. Electronic address: dr.ramazani@mimpharma.com.
  • Khorshiddoust SR; R&D Group, MIM Pharma, Oslo, Norway.
  • Hosseinabadi T; Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: t.hosseinabadi@sbmu.ac.ir.
  • Mottaghitalab F; R&D Group, MIM Pharma, Oslo, Norway. Electronic address: Faezeh.mottaghitalab@gmail.com.
  • Mokhtari F; R&D Group, MIM Pharma, Oslo, Norway.
  • Azadinia F; R&D Group, MIM Pharma, Oslo, Norway.
  • Mozdarani H; Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Shabani M; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Emadi-Kouchak H; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Taheri B; Nexus & HSE Center, Amirkabir University of Technology, Tehran, Iran.
  • Khani-Juyabad F; R&D Group, MIM Pharma, Oslo, Norway.
  • Kashani MA; R&D Group, MIM Pharma, Oslo, Norway.
  • Sadoughi A; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Zamanizadeh S; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Maddah H; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Aminzadeh M; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Khanaki M; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Saremi S; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Rad AP; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Fatehi A; Department of Industrial Engineering and Management Systems, Amirkabir University of Technology, Tehran, Iran.
  • Rad MG; R&D Group, MIM Pharma, Oslo, Norway.
  • Haftbaradaran M; MIM Daroo, Tehran, Iran.
  • Khosroshahi M; MIM Daroo, Tehran, Iran.
  • Sadeghi M; MIM Daroo, Tehran, Iran.
  • Aminnayeri M; Aramesh Multi-Professional Pain Clinic, Tehran, Iran.
  • Jafari S; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghiasvand F; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Seifi A; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghaderkhani S; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Manshadi SAD; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Salehi M; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Abbasian L; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Hasannezhad M; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Meidani M; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Hajiabdolbaghi M; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadinejad Z; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Parash M; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Sedighi Z; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohammadian A; Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Biomed Pharmacother ; 149: 112729, 2022 May.
Article em En | MEDLINE | ID: mdl-35276467
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article